SINGAPORE, 7 November 2023 – Duke-NUS Medical School (Duke-NUS) and IPGaia, Inc. (IPG) have signed an agreement to jointly advance drug discovery and development from academia to industry, to bring the benefits of translational research to patients. Through this partnership, Duke-NUS will propose drug targets to IPG, which will, in turn, identify and develop lead compounds with the goal of licensing clinic-ready candidates to pharmaceutical companies. The collaboration brings together IPG’s expertise in commercial research and development and its industry network with Duke-NUS’ strong capabilities in world-class discovery research in areas of global importance. Aligning with Singapore’s national focus to build a vibrant ecosystem for biomedical innovation, Duke-NUS’ five …
Continue reading “Duke-NUS and Japan-based IPGaia announce partnership to accelerate innovation in drug discovery”